CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
pacemaker, artificialdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000561
NCT00000561Phase 3Completed
CompareCT.gov

Mode Selection Trial in Sinus Node Dysfunction (MOST)

Mt. Sinai Medical Center, Miami·interventional·Posted Oct 28, 1999·Updated Feb 23, 2016

In Brief

A Phase 3 clinical trial evaluating pacemaker, artificial for Arrhythmia and 5 related conditions. Completed.

Detailed Summary

To determine if dual chamber rate-modulated pacing (DDDR) in patients with sick sinus syndrome is superior to single chamber pacing (VVIR) with respect to subsequent frequency of adverse clinical events such as stroke, quality of life and function, and cost effectiveness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiovascular Diseases, Heart Diseases, Sick Sinus Syndrome, Vascular Diseases, Cerebrovascular Accident
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJun 1, 1995
Study CompletionMay 1, 2002
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

pacemaker, artificialdevice